Enlivex Therapeutics Ltd. (ENLV)
USD 0.89
(-3.52%)
USD 0.89
(-3.52%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -23.52 Million | -23.95 Million | -17.54 Million | -11 Million | -7.04 Million | -3.16 Million |
| Net Income | -29.06 Million | -31.06 Million | -14.46 Million | -11.82 Million | -9.38 Million | -4.24 Million |
| Depreciation & Amortization | 835 Thousand | 777 Thousand | 546 Thousand | 286 Thousand | 206 Thousand | 121 Thousand |
| Deferred income taxes | -2.18 Million | - | -5.59 Million | - | 119 Thousand | - |
| Stock-based compensation | 1.95 Million | 2.71 Million | 2.91 Million | 670 Thousand | 810 Thousand | 1 Million |
| Change in working capital | -1.81 Million | 804 Thousand | -1.35 Million | -306 Thousand | 1.04 Million | 83 Thousand |
| Other non-cash items | 8.71 Million | 2.81 Million | 413 Thousand | 167 Thousand | 168 Thousand | -132 Thousand |
| Investing Cash Flow | -25.96 Million | 62.52 Million | -38.4 Million | -20.97 Million | -6.35 Million | -533 Thousand |
| Investments in PPE | -236 Thousand | -8.12 Million | -1.62 Million | -1.01 Million | -193 Thousand | -461 Thousand |
| Acquisitions | 133 Thousand | -9.7 Million | -20.03 Million | - | 1.54 Million | - |
| Investment purchases | -26.16 Million | -1.6 Million | -104.41 Million | -19.95 Million | -7.71 Million | -40 Thousand |
| Sales/Maturities of investments | 301 Thousand | 72.25 Million | 67.63 Million | - | -1.54 Million | - |
| Other Investing Activities | -25.73 Thousand | 9.7 Million | 20.03 Million | -19.95 Thousand | 1.54 Million | -32 Thousand |
| Financing Cash Flow | 360 Thousand | 150 Thousand | 60.98 Million | 33.08 Million | 8.3 Million | 5.19 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 360 Thousand | 150 Thousand | 53.17 Million | 24.46 Million | 7.7 Million | 5.19 Million |
| Other Financing Activities | 360.00 | 150.00 | 7.8 Million | 8.61 Million | 599 Thousand | 5194.00 |
| Accounts receivables | 608 Thousand | 278 Thousand | -1.24 Million | 1.82 Million | 41 Thousand | -130 Thousand |
| Accounts payables | -1.12 Million | 1.16 Million | 442 Thousand | 36 Thousand | 114 Thousand | 145 Thousand |
| Inventory | - | -278 Thousand | 1.24 Million | -1.82 Million | -41 Thousand | - |
| Other working capital | -1.3 Million | -364 Thousand | -1.79 Million | -342 Thousand | 926 Thousand | -62 Thousand |
| Cash at beginning of period | 49.94 Million | 11.63 Million | 7.01 Million | 5.52 Million | 9.79 Million | 9 Million |
| Cash at end of period | 926 Thousand | 50.35 Million | 11.63 Million | 7.01 Million | 5.52 Million | 9.73 Million |
| Capital Expenditure | -236 Thousand | -8.12 Million | -1.62 Million | -1.01 Million | -193 Thousand | -461 Thousand |
| Effect of forex changes on cash | 112 Thousand | - | -408 Thousand | 390 Thousand | 826 Thousand | -769 Thousand |
| Net cash flow / Change in cash | -49.01 Million | 38.72 Million | 4.62 Million | 1.48 Million | -4.26 Million | 731 Thousand |
| Free Cash Flow | -23.75 Million | -32.07 Million | -19.16 Million | -12.02 Million | -7.23 Million | -3.62 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.09 Million | -4.14 Million | -9.09 Million | -29.06 Million | -5.96 Million | -6.79 Million |
| Depreciation & Amortization | 160 Thousand | 188 Thousand | 200 Thousand | 835 Thousand | 214 Thousand | 212 Thousand |
| Deferred income taxes | - | - | -112.87 Thousand | -2.18 Million | 102 Thousand | 234 Thousand |
| Stock-based compensation | 388 Thousand | 383 Thousand | 400 Thousand | 1.95 Million | 407 Thousand | 511 Thousand |
| Change in working capital | 573.21 Thousand | -962 Thousand | 993.35 Thousand | -1.81 Million | -415 Thousand | -1.41 Million |
| Other non-cash items | -148.13 Thousand | 608 Thousand | 2.98 Million | 8.71 Million | 216 Thousand | 226 Thousand |
| Investing Cash Flow | -829.27 Thousand | 5.09 Million | 4.09 Million | -25.96 Million | 3.94 Million | -2.7 Million |
| Investments in PPE | -15.51 Thousand | -42.99 Thousand | -5938.30 | -236 Thousand | -29 Thousand | -38 Thousand |
| Acquisitions | -843.90 | 224 Thousand | 48.91 Thousand | 133 Thousand | -1267.40 | 80.68 Thousand |
| Investment purchases | -10.13 Million | -8.48 Million | 4.04 Million | -26.16 Million | 3.97 Million | -3.03 Million |
| Sales/Maturities of investments | 9.32 Million | 13.4 Million | 11.51 Thousand | 301 Thousand | -4451.36 | 288 Thousand |
| Other Investing Activities | 1000.00 | 53 Thousand | 4142.00 | -25.73 Thousand | 5718.77 | 1318.00 |
| Financing Cash Flow | 4.37 Million | 524 Thousand | -1282.92 | 360 Thousand | -5564.20 | 42 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | -110 Thousand |
| Common Stock Issuance | 4.37 Million | 524 Thousand | -1282.92 | 360 Thousand | -5564.20 | 42 Thousand |
| Other Financing Activities | 4.41 Million | 524 Thousand | - | 360.00 | - | 152 Thousand |
| Accounts receivables | 1.42 Million | 355 Thousand | 251.57 Thousand | 608 Thousand | 501.37 Thousand | -658.28 Thousand |
| Accounts payables | -336.7 Thousand | -183 Thousand | 35.95 Thousand | -1.12 Million | -914 Thousand | 217 Thousand |
| Inventory | - | - | 1.00 | - | -501.37 Thousand | 658.28 Thousand |
| Other working capital | -512.39 Thousand | -1.13 Million | 705.82 Thousand | -1.3 Million | 499 Thousand | -1.63 Million |
| Cash at beginning of period | 2.02 Million | 926 Thousand | 2.08 Million | 49.94 Million | 3.86 Million | 13.54 Million |
| Cash at end of period | 3.86 Million | 2.02 Million | 926 Thousand | 926 Thousand | 2.36 Million | 3.86 Million |
| Capital Expenditure | -15.51 Thousand | -42.99 Thousand | -5938.30 | -236 Thousand | -29 Thousand | -38 Thousand |
| Effect of forex changes on cash | - | - | -227.08 Thousand | 112 Thousand | 5564.20 | - |
| Net cash flow / Change in cash | 1.83 Million | 1.09 Million | -1.15 Million | -49.01 Million | -1.49 Million | -9.68 Million |
| Free Cash Flow | -1.76 Million | -4.55 Million | -5.03 Million | -23.75 Million | -5.46 Million | -7.06 Million |
NSIL
OMAGQ
AAMAF
601609
600887
GOEL